FUM — Futura Medical Income Statement
0.000.00%
Last trade - 00:00- £6.63m
- £2.94m
- £13.93m
Annual income statement for Futura Medical, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 3.1 | 13.9 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 1.77 | 9.69 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2.93 | 5.87 | 6.87 | 10.1 | 12.7 |
| Operating Profit | -2.93 | -5.87 | -6.87 | -6.96 | 1.24 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.93 | -5.87 | -6.87 | -6.89 | 1.29 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.41 | -4.96 | -5.85 | -6.51 | 1.29 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.41 | -4.96 | -5.85 | -6.51 | 1.29 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.41 | -4.96 | -5.85 | -6.51 | 1.29 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.01 | -0.018 | -0.02 | -0.022 | 0.004 |